Vascular Insights Receives FDA Clearance for Infusion Catheter

 

May 6, 2008

May 6, 2008 - Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature.

ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.

Other products by the company include ClariVein-VA, which is engineered to allow varicose vein disease correction with a minimally invasive, small caliber (2 2/3 French), soft, flexible infusion catheter. ClariVein-IC, a general infusion catheter and can be used, for example, to treat Deep Vein Thrombosis (DVT). Exchanges are eliminated, and the system provides even, controlled irrigation, designed to facilitate well-dispersed drug coverage of the target tissue, reducing the washing away of the therapeutic agent into the bloodstream. The FDA has not as yet cleared ClariVein-VA and ClariVein-IC for marketing in the US.

For more information: www.vascularinsightsllc.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.